Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial (vol 109, pg 440, 2014)

被引：1
|
作者：
Konstenius, Maija
Jayaram-Lindstroem, Nitya
Guterstam, Joar
Beck, Olof
Philips, Bjoern
Franck, Johan
机构：
来源：
ADDICTION | 2014年 / 109卷 / 09期
关键词：
D O I：
10.1111/add.12674
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：1571 / 1572
页数：4
相关论文
共 50 条
  • [1] Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial
    Konstenius, Maija
    Jayaram-Lindstroem, Nitya
    Guterstam, Joar
    Beck, Olof
    Philips, Bjoern
    Franck, Johan
    [J]. ADDICTION, 2014, 109 (03) : 440 - 449
  • [2] METHYLPHENIDATE FOR ADHD IN ADULTS WITH SUBSTANCE DEPENDENCE A 24-WEEK RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Konstenius, M.
    Jayaram-Lindstrom, N.
    Guterstam, J.
    Philips, B.
    Beck, O.
    Franck, J.
    [J]. EUROPEAN PSYCHIATRY, 2013, 28
  • [3] A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
    Biederman, J
    Mick, E
    Surman, C
    Doyle, R
    Hammerness, P
    Harpold, T
    Dunkel, S
    Dougherty, M
    Aleardi, M
    Spencer, T
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (09) : 829 - 835
  • [4] Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: A pilot randomized placebo-controlled trial
    Hurt, Richard D.
    Ebbert, Jon O.
    Croghan, Ivana T.
    Schroeder, Darrell R.
    Sood, Amit
    Hays, J. Taylor
    [J]. JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE, 2011, 10
  • [5] A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder
    Michael Rösler
    Roland Fischer
    Richard Ammer
    Claudia Ose
    Wolfgang Retz
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 2009, 259 : 368 - 368
  • [6] A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder
    Roesler, Michael
    Fischer, Roland
    Ammer, Richard
    Ose, Claudia
    Retz, Wolfgang
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2009, 259 (02) : 120 - 129
  • [7] A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder
    Michael Rösler
    Roland Fischer
    Richard Ammer
    Claudia Ose
    Wolfgang Retz
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 2009, 259 : 120 - 129
  • [8] A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder (vol 259, pg 120, 2009)
    Roesler, Michael
    Fischer, Roland
    Ammer, Richard
    Ose, Claudia
    Retz, Wolfgang
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2009, 259 (06) : 368 - 368
  • [9] Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Young, Joel L.
    Sarkis, Elias
    Qiao, Meihua
    Wietecha, Linda
    [J]. CLINICAL NEUROPHARMACOLOGY, 2011, 34 (02) : 51 - 60
  • [10] Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial,"A Placebo-Controlled Randomized Clinical Trial (vol 61, pg 647, 2022)
    Johnstone
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (05): : 607 - 607
12345